Bioadaptives (BDPT) Change in Accured Expenses (2019 - 2025)
Bioadaptives' Change in Accured Expenses history spans 7 years, with the latest figure at $1957.0 for Q4 2025.
- Quarterly results put Change in Accured Expenses at $1957.0 for Q4 2025, down 79.49% from a year ago — trailing twelve months through Dec 2025 was $53267.0 (up 18.82% YoY), and the annual figure for FY2025 was $53267.0, up 18.82%.
- Change in Accured Expenses for Q4 2025 was $1957.0 at Bioadaptives, down from $26687.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $109110.0 in Q3 2021 to a low of -$16261.0 in Q3 2023.
- The 5-year median for Change in Accured Expenses is $12265.0 (2025), against an average of $26764.1.
- The sharpest move saw Change in Accured Expenses skyrocketed 11289.35% in 2021, then crashed 210.27% in 2023.
- Year by year, Change in Accured Expenses stood at $107924.0 in 2021, then tumbled by 89.27% to $11575.0 in 2022, then plummeted by 240.48% to -$16261.0 in 2023, then soared by 158.68% to $9542.0 in 2024, then plummeted by 79.49% to $1957.0 in 2025.
- According to Business Quant data, Change in Accured Expenses over the past three periods came in at $1957.0, $26687.0, and $12265.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.